ABOUT US

The name ‘Sanomics’ is derived from the word of Sanguis, the Latin word for blood, and genomics, which stands for the study of genes.

​

Since the launch of Sanomics, “Patient First” has always been our principle. Putting patients’ needs as our top priority, we strive to revolutionize current cancer treatments by providing safe and efficient liquid-based genomic tests to patients. We aim to provide easy and convenient access to our services and help doctors decide personalized cancer solutions for patients.

MISSION

Began in Hong Kong, Sanomics continues our footsteps in South East Asia. Aspiring to develop and deploy the latest genetic and genomic technologies, we strive to work with healthcare professionals from hospitals, clinics, and drug companies to benefit patients in Hong Kong and the pan-Asian region. Being a pioneering company in providing genomic tests market in Hong Kong, we are committed to serving patients from all over the world.